INCYTE CORPORATION

Business Segments Incyte Corporation

Stocks

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			5-day change	1st Jan Change
108.53 ^USD	+0.65%		+6.01%	+9.88%

06-11	Guggenheim Lifts Price Target on Incyte to $136 From $130, Maintains Buy Rating	MT
06-11	William O'Neil Initiates Incyte at Buy	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Biological Products
Oncology and Dermatology Pharmaceutical Products						2.99B	3.39B	3.7B	4.24B	5.14B
Total Assets						4.93B	5.84B	6.78B	5.44B	6.96B
Interest Expense						-1.91M	-2.67M	-2.55M	-2.28M	-2.43M
Income Tax Expense						-378M	188M	237M	284M	378M
CAPEX						-181M	-77.83M	-32.49M	-86.26M	-58.87M
EBT						570M	529M	834M	317M	1.66B
D&A						60.54M	67.86M	82.66M	89.25M	93.29M
Operating Income						586M	579M	621M	61.37M	1.51B
Net Income						949M	341M	598M	32.62M	1.29B

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
United States						2.9B	3.2B	3.5B	4B	4.8B
Total Assets						434M	442M	432M	474M	407M
Europe						124M	147M	-	260M	324M
Total Assets						287M	296M	314M	-	-
Total Assets						2.9M	1.5M	4.8M	-	-
Other Countries						-	-	-	6.2M	17.57M
Total Assets						-	-	-	11.7M	14.25M
Europe and Japan						-	-	179M	-	-
Total Assets						-	-	-	278M	310M

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!